Last reviewed · How we verify
cardamom
At a glance
| Generic name | cardamom |
|---|---|
| Also known as | Elettaria cardamomum |
| Sponsor | University of Karachi |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Cardamom and Topical Roseomonas in Atopic Dermatitis (PHASE2)
- Effect of Cardamom and Peppermint Oils on Chemotherapy-Related Nausea-Vomiting and Food Intake (NA)
- Role of Race in Nutritional Approach in Men on ADT (NA)
- A Study on the Application of Aromatherapy Combined With Transcranial Magnetic Stimulation in Insomnia of Stroke Patients (NA)
- Formulation, Phytochemical Characterization, and Clinical Assessment of a Novel Natural Supplement Targeting Body Composition in Physically Active Individuals (NA)
- Acceptability of Nutrient Supplements Among Women and Children in Bangladesh (NA)
- The Effect of Spice Consumption on Postprandial Vascular Function (NA)
- The Cognitive Effects of 'Brainwaves' Supplementation in Cognitively Intact Older Adults (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cardamom CI brief — competitive landscape report
- cardamom updates RSS · CI watch RSS
- University of Karachi portfolio CI